- Home
- CRGY vs CERT Comparison
CRGY vs CERT Comparison
Compare CRGY & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGY
- CERT
- Stock Information
- Founded
- CRGY 1986
- CERT 2008
- Country
- CRGY United States
- CERT United States
- Employees
- CRGY N/A
- CERT N/A
- Industry
- CRGY Oil & Gas Production
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- CRGY Energy
- CERT Technology
- Exchange
- CRGY Nasdaq
- CERT Nasdaq
- Market Cap
- CRGY 2.0B
- CERT 1.9B
- IPO Year
- CRGY N/A
- CERT 2020
- Fundamental
- Price
- CRGY $13.97
- CERT $11.60
- Analyst Decision
- CRGY Buy
- CERT Buy
- Analyst Count
- CRGY 12
- CERT 7
- Target Price
- CRGY $16.80
- CERT $15.92
- AVG Volume (30 Days)
- CRGY 3.8M
- CERT 1.3M
- Earning Date
- CRGY 11-04-2024
- CERT 11-06-2024
- Dividend Yield
- CRGY 3.45%
- CERT N/A
- EPS Growth
- CRGY 42.32
- CERT N/A
- EPS
- CRGY 0.53
- CERT N/A
- Revenue
- CRGY $2,713,358,000.00
- CERT $372,797,000.00
- Revenue This Year
- CRGY $25.74
- CERT $10.20
- Revenue Next Year
- CRGY $26.23
- CERT $10.43
- P/E Ratio
- CRGY $26.25
- CERT N/A
- Revenue Growth
- CRGY 12.60
- CERT 5.62
- 52 Week Low
- CRGY $9.88
- CERT $9.41
- 52 Week High
- CRGY $15.54
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- CRGY 45.83
- CERT 55.62
- Support Level
- CRGY $13.68
- CERT $11.05
- Resistance Level
- CRGY $14.90
- CERT $11.83
- Average True Range (ATR)
- CRGY 0.42
- CERT 0.50
- MACD
- CRGY -0.15
- CERT 0.06
- Stochastic Oscillator
- CRGY 18.66
- CERT 63.87
About CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.